Medical guidelines and performance measures: the need to keep them free of industry influence.
作者信息
Eichacker Peter Q, Natanson Charles
机构信息
Critical Care Medicine Department, National Institutes of Health, Bethesda, MD.
出版信息
Mens Sana Monogr. 2008 Jan;6(1):22-8. doi: 10.4103/0973-1229.33005.
Abstract
摘要
相似文献
1
Medical guidelines and performance measures: the need to keep them free of industry influence.医学指南与绩效指标：使其免受行业影响的必要性。
Mens Sana Monogr. 2008 Jan;6(1):22-8. doi: 10.4103/0973-1229.33005.
2
Current guidelines regarding industry-sponsored continuing medical education.关于行业资助的继续医学教育的现行指南。
Clin Orthop Relat Res. 2003 Jul(412):21-7. doi: 10.1097/01.blo.0000074411.99625.55.
3
Guidelines, editors, pharma and the biological paradigm shift.指南、编辑、制药行业与生物学范式转变
Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.
4
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.制药公司向肿瘤临床实践指南作者支付的个人报酬。
Oncologist. 2021 Sep;26(9):771-778. doi: 10.1002/onco.13823. Epub 2021 May 26.
5
Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey.出版行业资助的医学研究指南在出版专业人员中的知晓度与执行情况：全球出版调查
BMJ Open. 2014 Apr 19;4(4):e004780. doi: 10.1136/bmjopen-2013-004780.
6
Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.临床教员与制药行业互动指南：一所医学院的做法。
Acad Med. 2006 Feb;81(2):154-60. doi: 10.1097/00001888-200602000-00008.
7
Industry influence in the creation of pay-for-performance quality measures.行业在按绩效付费质量指标创建过程中的影响。
Qual Manag Health Care. 2008 Jan-Mar;17(1):27-34. doi: 10.1097/01.QMH.0000308635.59108.29.
8
Neurosurgery and industry.神经外科与产业
J Neurosurg. 2008 Dec;109(6):979-88. doi: 10.3171/JNS.2008.109.12.0979.
9
Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.利用文献制定麦吉尔大学关于住院医师与制药行业互动的指南。
Acad Med. 2004 Nov;79(11):1033-40. doi: 10.1097/00001888-200411000-00004.
10
Is keep/refer decision making an integral part of national guidelines for the physiotherapy profession within Europe? A review.在欧洲，是否将保留/转诊决策作为物理治疗专业国家指南的一个组成部分？综述。
Physiotherapy. 2017 Dec;103(4):352-360. doi: 10.1016/j.physio.2016.11.005. Epub 2016 Nov 28.
本文引用的文献
1
Guidance for guidelines.指南的指南。
N Engl J Med. 2007 Jan 25;356(4):331-3. doi: 10.1056/NEJMp068282.
2
What have we learnt from Vioxx?我们从万络中学到了什么？
BMJ. 2007 Jan 20;334(7585):120-3. doi: 10.1136/bmj.39024.487720.68.
3
Improving the use of research evidence in guideline development: 16. Evaluation.提高研究证据在指南制定中的应用：16. 评估。
Health Res Policy Syst. 2006 Dec 8;4:28. doi: 10.1186/1478-4505-4-28.
4
Improving the use of research evidence in guideline development: 1. Guidelines for guidelines.提高研究证据在指南制定中的应用：1. 指南制定指南。
Health Res Policy Syst. 2006 Nov 21;4:13. doi: 10.1186/1478-4505-4-13.
5
Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly.脓毒症存活——实践指南、营销活动与礼来公司
N Engl J Med. 2006 Oct 19;355(16):1640-2. doi: 10.1056/NEJMp068197.
6
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.引发利益冲突的医疗行业行为：针对学术医疗中心的一项政策提案
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.
7
Drotrecogin alfa (activated) in severe sepsis.
N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6.
8
Drotrecogin alfa (activated) in severe sepsis.
N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6.
9
Drotrecogin alfa (activated) in severe sepsis.重组人活化蛋白C用于严重脓毒症
N Engl J Med. 2006 Jan 5;354(1):94-6; author reply 94-6. doi: 10.1056/NEJMc052759.
10
Cash interests taint drug advice.金钱利益玷污药物建议。
Nature. 2005 Oct 20;437(7062):1070-1. doi: 10.1038/4371070a.
Zotero 插件